Foot and Ankle Devices Market Size & Share 2026-2035

Foot and Ankle Devices Market Size

The global foot and ankle devices market was estimated at USD 5.3 billion in 2025. The market is expected to grow from USD 5.7 billion in 2026 to USD 10.4 billion in 2035, at a CAGR of 6.9% during the forecast period, according to the latest report published by Global Market Insights Inc.

The market is driven by numerous factors such as increasing prevalence of orthopedic disorders, rising incidence of trauma and road accidents, and technological advancements in foot and ankle devices, among other factors. A growing diabetic population leading to foot complications, the development of patient-specific implants, and a growing focus on minimally invasive & arthroscopic innovations are expected to fuel the industry's growth. Stryker, DePuy Synthes (Johnson & Johnson), Arthrex, Zimmer Biomet, and Enovis are among the leading players operating in the market. These players mainly focus on product innovation, geographic expansion, integration of advanced technologies in devices, strong R&D, and collaboration with local or regional healthcare providers, among others.
 

The market has increased from USD 3.9 billion in 2022 and reached USD 4.8 billion in 2024, with the historic growth rate of 10.7%. The increasing number of orthopedic and musculoskeletal disorders is contributing significantly to the growth of the foot-and-ankle devices market. Osteoarthritis, along with traumatic fractures, tendon injuries, and degenerative joint diseases, is rising throughout the world, significantly affecting people's ability to move around and enjoy life.

In addition, the growing burden of the elderly population, along with the rising incidence of lifestyle-related risk factors, supports the growing prevalence of these disorders, pushing the demand for advanced foot-and-ankle treatment options. For instance, according to the World Health Organization (WHO), musculoskeletal conditions affect approximately 1.71 billion people globally, making them the leading contributor to disability and functional limitations, which include low back pain, neck pain, fractures and other injuries, and osteoarthritis, among others.
 

The growing global burden of trauma, especially injuries resulting from road traffic accidents, is a major factor accelerating demand for foot and ankle devices, which are critical for managing fractures, ligament tears, dislocations, and other lower‑extremity injuries that frequently occur in high‑impact accidents. For example, according to the World Health Organization (WHO), approximately 1.19 million people die every year due to road traffic crashes, making road injuries a major global health concern. Road traffic injuries are the leading cause of death among children and young adults aged 5–29 years, highlighting their disproportionate impact on younger populations. This growing volume of trauma cases is steadily supporting the demand for foot and ankle devices in the market.
 

The foot and ankle devices market is being influenced by the rise of technological innovation. The introduction of new technologies and improvements in material science and device engineering have contributed substantially to the improvement of patients' outcomes who suffer from injuries or disorders of the foot and ankle. Many companies are now using advanced biomaterials, such as optimized alloys and porous 3D-printed structures, that replicate the architecture of bone and provide enhanced osseointegration. An example is Exactech’s Vantage Ankle 3D and 3D+ tibial implants, which incorporate 3D‑printed porous surfaces and advanced polyethylene designed to enhance fixation strength and long‑term durability. This engineering design results in the implants delivering strength and precision during ankle replacement surgery.
 

Foot and ankle devices are medical devices specifically designed to diagnose, treat, support, and manage conditions affecting the foot and ankle. These devices are used in a wide range of foot and ankle conditions, injuries, and disorders.

Foot and Ankle Devices Market Trends

Rising use of 3D-printed and patient-specific implants, growing integration of biologics in foot & ankle repair, expansion of sports medicine and trauma-related procedures, shift toward minimally invasive foot & ankle procedures, and advancements in smart wearables and monitoring devices are among the key trends shaping the market growth.
 

• Custom fit, enhanced biomechanics, and accelerated surgical workflow are among the few reasons hospitals and surgeons are choosing 3D-printed implants as their method of choice for custom solutions. With the growing need for patient-specific products in complicated deformities and revisions, manufacturers have started a trend to integrate additive manufacturing technology in their product development pipelines.
   
• Additionally, biologics, including bone graft substitutes, growth factors, and regenerative matrices, are being used more frequently to increase the rate of healing. The enhanced bone fusion and soft tissue repair from biologics creates a synergy with implants, leading to a combined device/biologic approach to the treatment of patients with trauma or reconstructive procedures.
   
• Further, rising levels of sports activity and injury occurrences are propelling the need for enhanced fixation systems, ligament repair devices, and support orthobiologics. Younger patients prefer more rapid recovery and increased mobility after surgery, and they are helping to drive new implant innovations specifically designed for high-activity populations.
   
• Moreover, smart orthopedic wearables with sensors for gait analysis, pressure distribution, and rehabilitation tracking are emerging as supportive tools in postoperative care. These devices are anticipated to improve the post-surgical outcomes, thereby supporting market growth.
   

Foot and Ankle Devices Market Analysis

Based on product, the global market is segmented into orthopedic implants and devices, bracing and support devices, and prostheses. The orthopedic implants and devices segment accounted for a majority share of 70.3% in 2025. Growth in 3D-printed orthopedic implants is anticipated to fuel the segmental growth. The segment is expected to reach USD 7.6 billion by 2035, growing at a CAGR of 7.4% during the forecast period.
 

• The orthopedic implants and devices segment constitutes the largest share of the global market, driven by high procedural volumes associated with trauma, deformity correction, and degenerative joint conditions.
   
• This high growth is supported by the rising incidence of lower extremity fractures, diabetes-related foot complications, age-related musculoskeletal degeneration, and sports and recreational injuries worldwide.
   
• In addition, orthopedic implants and devices are the primary treatment option for surgical management of foot and ankle conditions. They are widely used for trauma fixation, joint degeneration, deformity correction, and reconstruction procedures. The segment includes fracture fixation systems such as plates, screws, nails, joint replacement implants, and soft-tissue repair products, among others.
   
• The bracing and support devices segment is expected to grow at a CAGR of 3.8% during the forecast period. It includes ankle-foot orthoses (AFOs), which can be used to manage patients with drop foot or other neuromuscular conditions; ankle braces/stabilizers that are designed for use with acute sprains and chronic conditions of instability, and other devices that either stabilize or assist in walking function.
   
• In terms of rehabilitation and clinical management, braces or support devices are clinically significant in a variety of conditions, including ankle sprains, stress fractures, plantar fasciitis, Achilles tendon injuries, and post-surgical rehabilitation periods following fracture repairs or soft tissue injuries.
   
• The prostheses segment is anticipated to reach over USD 1 billion by 2035. This growth is primarily due to the growing incidence of diabetes peripheral arterial disease, as well as aging populations whose numbers may contribute to high rates of lower extremity amputation due to listed parameters.
   
• Technological advancements within the prosthetics market are focused on improving user functionality through the use of lightweight composite materials (for prosthetic feet/ankles) and employing modular designs that utilize 3D scanning and additive processes for producing custom prosthetic devices.
   
• These advances in prosthetic devices allow for improvements in usability through better fitment, shortened time for production, and improved user comfort, which is a critical aspect of partial foot/ankle prostheses due to the high variability of anatomy in this part of the body.
   

Based on application, the global foot and ankle devices market is segmented into trauma, hammertoe, osteoarthritis, rheumatoid arthritis, neurological disorders, osteoporosis, and other applications. The trauma segment accounted for a leading share of 31.2% in 2025.
 

• Foot and ankle devices used for trauma are the largest category in this market. The trauma devices include the repair of acute fractures, dislocations, ligamentous injury, and soft tissue disruption caused by trauma from a high-impact incident such as trauma from an automobile accident, fall from a height, industrial accident, sport-related injury, or crushing injury.
   
• There is an emphasis within trauma management on rapid stabilization, restoring anatomical alignment, and early mobilization, which may create a demand for both internal and external fixation devices.
   
• Stabilizing fractures with plates and screws remains the primary method of final stabilization of stable fractures, while external fixation is used to stabilize open fractures or in patients with a significant soft tissue injury or in polytrauma patients requiring a staged reconstruction process.
   
• The hammertoe segment is witnessing significant growth with a revenue of USD 876.8 million in 2025 to a projected USD 1.8 billion by 2035. Hammertoe is among the most frequent forefoot deformities. Hammertoe results from muscle weakness in the foot that interferes with balance. For instance, those weak intrinsic muscles on the inside of the foot are overpowered by the stronger extrinsic muscles on the outside of the foot at those metatarsophalangeal joints (MTPJ) of the lesser digits.
   
• Additionally, correcting hammertoes involves all types of implant materials, including nails or rods, fixation devices such as plates, wires, and pins, and soft tissue materials such as tapes or sutures, among others. Hence, this segment represents a substantial area of revenue contribution across many product lines.
   
• The osteoarthritis segment was valued at USD 1.1 billion in 2025. Osteoarthritis represents the most common degenerative joint disease affecting the foot and ankle, characterized by progressive articular cartilage degradation, subchondral bone remodeling, osteophyte formation, synovial inflammation, and eventual joint space collapse leading to pain, stiffness, deformity, and functional limitation
   
• Further, rising prevalence of degenerative joint disease affecting the ankle, subtalar, and midfoot joints is a key driver of the market. In addition, technological progress has significantly influenced surgical decision-making within the OA segment, particularly through advances in total ankle replacement systems.
   

Based on end use, the foot and ankle devices market is segmented into hospitals, ambulatory surgical centers, orthopedic clinics, and other end-users. The hospitals segment accounted for the leading market share of 56.5% in 2025.
 

• This is the largest segment in the foot and ankle devices end users category. Primary function is to address high acuity trauma, advanced reconstructive procedures, and patients with multi-comorbidities. They remain the go to location for treating severe ankle fractures, correcting deformed feet, and replacing and revising total ankles that may require a longer period of postoperative supervision and care, and require input from multiple disciplines.
   
• Additionally, the aging population is responsible for a large portion of hospital admissions and as the numbers continue to rise, the need for durable fixation systems, fusion nails, and implants for the ankle joint increases. Similarly, the growing incidence of ankle arthritis and falls, as well as fractures due to decreased bone density among geriatric patients has fueled the demand for long-term, mobility-preserving treatments.
   
• The ambulatory surgical centers segment was valued at USD 1.3 billion in 2025 and is expected to grow at a CAGR of 6.7% during the forecast period. Ambulatory surgical centers (ASCs) are among the highest-growth sectors in the healthcare facilities, striking a chord with a global shift toward outpatient orthopedic surgical care and minimally invasive treatment paradigms for foot and ankle surgery.
   
• Further, the technological developments in anesthesia, pain management, and surgical instrumentation have allowed ASCs to facilitate an increasing number of outpatient foot and ankle procedures (such as bunion and hammertoe corrections, ligament reconstruction, and certain fixation surgeries) safely in the outpatient environment.
   
• Moreover, the average cost per outpatient procedure in ASCs typically is less when compared to procedure performed in hospital outpatient departments because ASCs typically have more cost-effective operational models, overhead, and scheduling efficiencies for surgery than their counterparts. Therefore, ASCs are attractive to private payers and governmental payers who want to reduce costs for orthopedic treatment while maintaining a high level of clinical quality and safety.
   

North America Foot and Ankle Devices Market

North America market accounted for majority share of 54.5% in 2025 in the global market and is anticipated to show notable growth over the forecast period.
 

• The U.S. market was valued at USD 2 billion and USD 2.2 billion in 2022 and 2023, respectively. In 2025 the market size was valued at USD 2.6 billion from USD 2.4 billion in 2024. Development of patient-specific implants is projected to fuel the market growth.
   
• Additionally, the expansion can be attributed to having a well-developed medical care infrastructure, high surgical procedure volumes, an established reimbursement structure, significant research and development activity, and easily accessible podiatric and orthopedic specialists in the area.
   
• Further, the region is among the global innovation leaders for foot and ankle devices. Significant developments in the industry pertaining to new technologies, such as the total ankle replacement systems, far cortical locking screws, synthetic cartilage implants, and hexapod external fixation frames, have been developed, clinically tested, and launched first in the U.S. before being commercialized internationally.
   

Europe Foot and Ankle Devices Market

Europe accounted for a significant share of the global market and was valued at USD 1.2 billion in 2025.
 

• The European market is characterized by advanced healthcare systems with universal or near-universal coverage, established regulatory frameworks, and diverse country-specific reimbursement environments creating heterogeneous adoption patterns.
   
• Additionally, according to Eurostat, as of Jan 2024, more than one-fifth (21.6%) of the region's population was aged 65 years and over. This aging demographic directly increases the incidence of degenerative foot and ankle conditions, osteoporotic fractures, and balance-related injuries, sustaining long-term demand for fixation devices, joint implants, and supportive orthopedic solutions.
   
• Surgical procedure volumes related to the foot and ankle continue to rise gradually across Europe, particularly for fracture fixation, forefoot deformity correction, and arthritis-related reconstructions.
   
• Further, national healthcare databases in countries such as Germany, France, and the UK report consistent annual growth in lower-extremity orthopedic procedures, driven by aging populations and improved access to specialist care.
   

Asia Pacific Foot and Ankle Devices Market

The Asia Pacific market accounted for a substantial share of the market and was valued at USD 780.9 million in 2025.
 

• This high growth is driven by rapid economic development, growing middle-class populations, increasing healthcare expenditure, a rising patient base, and progressive insurance coverage expansion.
   
• Asia Pacific countries with developed economies, including Japan, Australia, South Korea, and Singapore, exhibit steady growth in orthopedic surgical cases across all areas, including fracture fixation, deformity correction, and joint reconstruction. Whereas large emerging markets like China and India have large volumes of orthopedic patients, they exhibit low rates of surgical penetration on a per capita basis, thus demonstrating significant unmet demand for foot and ankle devices in these geographic areas.
   
• Additionally, device manufacturers may find long-term success in the region depending upon their portfolio's overall affordability, the ability to design products at scale, and their ability to align with the direction of the current public healthcare systems. Overall, the Asia Pacific region represents a volume-led, access-oriented, and diverse geographical region in the foot and ankle devices industry.
   

Latin America Foot and Ankle Devices Market

The Latin American market is anticipated to exhibit remarkable growth during the analysis period.
 

• The market is primarily shaped by injury-driven demand and public healthcare procurement dynamics. Growth is concentrated in trauma care, infection-related reconstructions, and deformity correction, particularly within public hospital systems.
   
• The aging population across countries such as Brazil, Colombia, and Mexico is fueling a steady rise in trauma-related foot and ankle fractures. For example, according to the Pan American Health Organization (PAHO), road traffic injuries account for a high share of lower-extremity fractures in these countries.
   
• Additionally, the region has a shortage of foot- and ankle-trained orthopedic specialists, with expertise concentrated in metropolitan centers.
   

Middle East and Africa Foot and Ankle Devices Market

The Middle East and Africa market is expected to experience substantial growth over the analysis timeframe.
 

• GCC governments are investing heavily in tertiary hospitals, trauma centers, and orthopedic subspecialty services as part of national healthcare transformation programs (e.g., Saudi Vision 2030). Expansion of orthopedic capacity is increasing procedure availability rather than merely shifting existing volumes.
   
• In addition, the region is experiencing a rapid increase in elderly populations. For instance, according to United Nations Population Division data, the population aged 60 years and above in the Middle East is projected to grow at a faster rate than the global average over the next two decades.
   
• Moreover, countries such as the UAE, Saudi Arabia, Turkey, and Jordan are positioning themselves as medical tourism hubs, including orthopedic and trauma care. This drives demand for internationally branded foot and ankle implants, particularly in private hospitals.
   

Foot and Ankle Devices Market Share

The global market for foot and ankle devices is dominated by established players in the orthopedic and sports medicine industries. There is a consistent trend among both multinational corporations and niche device manufacturers focusing on product innovation. In order to remain competitive in this growing sector, all manufacturers are involved with multiple strategies in order to improve their market presence through acquisitions, broad product offerings, technological advancements, and expanding into new geographical markets. Stryker, DePuy Synthes (Johnson & Johnson), Zimmer Biomet, and Arthrex are among the major players shaping the future of this market.
 

Additionally, all the leading manufacturers in this market are actively engaged in developing innovative foot and ankle implants, fixation systems, arthroscopic solutions, and surgical instrumentation that provide enhanced clinical results, improved surgical precision, and quicker recovery times for patients. Their product lines are designed for use across different types of conditions, including traumatic fractures, sports-related injuries, deformity correction, degenerative joint disease, and reconstructive surgeries. An emphasis on minimally invasive techniques, anatomical implant designs, and ease of use for surgeons has placed these manufacturers at the forefront of innovation in foot and ankle care.
 

Further, trends in the market are driven by the introduction of anatomically contoured implants, enhanced fixation technologies and progressive arthroscopic systems designed for foot and ankle procedures. In addition, there is a notable shift toward enhanced plate systems, internal fixation solutions and advanced ankle replacement technologies. Furthermore, the use of digital surgical planning tools, navigation technologies and intraoperative imaging integration may allow for more accurate procedures as well as individualized treatment plans.
 

Moreover, major companies continue to increase their investment in clinical research, product training programs and surgeon education, while expanding their footprint into emerging markets to meet the increasing volume of procedures and demand for advanced orthopedic solutions.
 

Foot and Ankle Devices Market Companies

A few of the prominent players operating in the global foot and ankle devices industry include:

• aap implantate AG
• Acumed LLC
• Arthrex, Inc.
• CONMED Corporation
• DePuy Synthes (Johnson & Johnson)
• Embla Medical Corporation
• Enovis Corporation
• Fillauer LLC
• Medartis
• Orthofix Medical Inc.
• Ottobock SE & Co KGaA
• Smith & Nephew  plc
• Stryker Corporation
• VILEX, LLC
• Zimmer Biomet Holdings, Inc.
   

• Stryker

Stryker focuses on expanding its orthopedic portfolio through continuous product innovation, surgeon‑focused training programs, and strategic acquisitions, while strengthening global distribution networks and improving procedural efficiency through integrated surgical technologies.
 

• DePuy Synthes (Johnson & Johnson)

DePuy Synthes emphasizes developing comprehensive trauma and reconstruction solutions, leveraging J&J’s clinical expertise, investing in next‑generation biomaterials, and expanding digital surgical platforms to enhance clinical outcomes and surgeon workflow efficiency worldwide.
 

• Enovis

Enovis concentrates on high‑growth orthopedic segments through innovation in bracing, reconstructive implants, and digital solutions, supported by operational excellence, targeted acquisitions, and a strong focus on clinician‑driven product development.
 

Foot and Ankle Devices Industry News:

• In April 2025, Zimmer Biomet completed the acquisition of Paragon 28, a company focused exclusively on the foot and ankle orthopedic segment, strengthening its position in one of the fastest‑growing areas of musculoskeletal care. The transaction expanded Zimmer Biomet’s foot and ankle portfolio and enabled the creation of a dedicated commercial channel supported by Paragon 28’s specialized sales organization.
   
• In September 2024, Stryker Corporation announced the launch of two new products under its foot and ankle lineup, the Osteotomy Truss System (OTS) and Ankle Truss System (ATS). This product launch enables the company to further solidify its market position by offering cutting-edge products and solutions in the foot and ankle category.
   
• In January 2024, Össur completed the acquisition of FIOR & GENTZ, a manufacturer specializing in lower limb orthotic components, expanding its capabilities in ankle-foot and neuro-orthotic solutions. The acquisition strengthened Össur’s portfolio in functional foot and ankle bracing and enhanced its ability to serve patients with neurological and mobility impairments.
   

The global foot and ankle devices market research report includes an in-depth coverage of the industry with estimates and forecasts in terms of revenue in (USD Million) from 2022 - 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Orthopedic implants and devices
  • Joint implants
    • Ankle implants
    • Other joint implants
  • Fixation devices
    • Internal fixation devices
      • Plates
      • Screws
      • Fusion nails
      • Other internal fixation devices
    • External fixation devices
      • Ring fixation systems
      • Pin-to-bar systems
      • Hexapod systems
      • Other external fixators
  • Soft tissue orthopedic devices
• Bracing and support devices
  • Soft bracing & support devices
  • Hard braces & support devices
  • Hinged braces & support devices
• Prostheses

Market, By Application

• Trauma
• Hammertoe
• Osteoarthritis
• Rheumatoid Arthritis
• Neurological Disorders
• Osteoporosis
• Other applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Orthopedic clinics
• Other end users
   

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE